<DOC>
	<DOCNO>NCT00557700</DOCNO>
	<brief_summary>This trial compare outcome treatment mild moderate asthma : inhaled tiotropium bromide versus placebo .</brief_summary>
	<brief_title>Study Investigate Effect Inhaled Tiotropium Bromide Neurokinin-A Induced Bronchoconstriction Patients With Mild-to-moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Informed consent Male female , least 18 year old Documented medical history asthma ( diagnosis least 6 month ago ) Nonsmoker least stop 1 year ( case smoke earlier : maximum 10 packyears ) Able conduct technically acceptable spirometry , methacholine neurokininA provocation test . At visit 1 : PC20 methacholine ≤ 8 mg/ml AND ≤ 3.3x107 mol/ml neurokininA provocation test . At visit 1 : force expiratory value one second &gt; = 80 % predict value . Female subject may get pregnant use adequate contraception . Airway infection within 6 week prior first study visit . Other respiratory disease ( eg COPD , lung cancer , etc . ) Participating another clinical trial . Clinically relevant systemic disease , asthma . Clinically significant laboratory deviation . Alcohol drug abuse . Female subject lactate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Mild moderate asthma</keyword>
</DOC>